Letha Haynes, Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 948 Cambridge Dr Ste 102, La Place, LA 70068 Phone: 985-652-7717 |
News Archive
A new study examined the knowledge and attitudes of anesthesiologists regarding the strategies used to treat suspected or confirmed COVID-19 patients needing to be operated on or cared for after surgery in an intensive care unit.
Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced that researchers presented positive new data from a Phase 1b study of the company's lead product candidate, OTO-104, in patients with Meniere's disease.
A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool that allows for more accurate measurement of the number, subtype, and activity of cancer antigen-specific CD4+ T cells in cancer patients treated with therapeutic cancer vaccines. The new technology may significantly aid tumor immunologists around the world who are working to improve the effectiveness of this emerging and highly promising class of immune system-based cancer therapies.
In a new retrospective study, researchers found that the use of immunosuppressive therapy does not increase the occurrence or recurrence of vulvar or vaginal cancer in women with inflammatory bowel disease (IBD).
Although the name may suggest otherwise, Parkinson's disease is not one but two diseases, starting either in the brain or in the intestines.
› Verified 3 days ago